RegenETP Inc.
RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, rep… Read more
RegenETP Inc. (RGTPQ) - Total Liabilities
Latest total liabilities as of March 2023: $5.63 Million USD
Based on the latest financial reports, RegenETP Inc. (RGTPQ) has total liabilities worth $5.63 Million USD as of March 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
RegenETP Inc. - Total Liabilities Trend (2019–2022)
This chart illustrates how RegenETP Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
RegenETP Inc. Competitors by Total Liabilities
The table below lists competitors of RegenETP Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acma Ltd
F:AAX1
|
Germany | €5.27 Million |
|
PT Utama Radar Cahaya Tbk
JK:RCCC
|
Indonesia | Rp57.50 Billion |
|
Media Central Corporation Inc
PINK:FBOP
|
USA | $2.68 Million |
|
Clean Energy Transition Inc.
V:TRAN
|
Canada | CA$5.29 Million |
|
Williamson Magor & Company Limited
NSE:WILLAMAGOR
|
India | ₹2.28 Billion |
|
BLAZE Minerals Ltd
AU:BLZ
|
Australia | AU$1.98 Million |
|
Rimoni
TA:RIMO
|
Israel | ILA44.06 Million |
Liability Composition Analysis (2019–2022)
This chart breaks down RegenETP Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RegenETP Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RegenETP Inc. (2019–2022)
The table below shows the annual total liabilities of RegenETP Inc. from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $6.23 Million | -47.80% |
| 2021-12-31 | $11.93 Million | -34.33% |
| 2020-12-31 | $18.17 Million | +23.76% |
| 2019-12-31 | $14.68 Million | -- |